
Job details
Job title
Postdoctoral Research Scientist - Dr Leo Carlin
Job reference
REQ00317
Date posted
15/11/2023
Application closing date
08/12/2023
Location
Glasgow
Salary
Salary: From £32,868 to £42,717 (Depending on experience) plus relocation allowance and visa costs if required.
Package
Blank
Contractual hours
35
Basis
Full time
Job category/type
Postdoctoral Fellows
Attachments
Blank
Job description
Scotland Institute Lab: Leukocyte Dynamics Lab (Carlin)
Project Title: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
Salary: From £32,868 to £42,717 (Depending on experience) plus relocation allowance and visa costs if required.
Contract term: Fixed term for 36 months
About us
The CRUK Scotland Institute is a cancer research institute situated in Glasgow with approximately 250 researchers split across 30 research groups consisting of PIs, postdoctoral scientists, PhD students and scientific officers. It is one of Europe's leading cancer research centres, supporting cutting-edge work into the molecular mechanisms of cancer development. As well as core support from Cancer Research UK, the Institute also receives an additional third of its total income from external grants and industry collaborations. It has an excellent reputation for fundamental cancer research, including world-class metabolism studies and renowned in vivo modelling of tumour growth and metastasis. Its research ethos is about excellence, honesty, openness, accountability and integrity.
Project outline
A postdoctoral position is available for an ambitious, creative and translationally minded scientist to join the Carlin group as part of an exciting multi-disciplinary project between the Mann (Newcastle), Bird (Glasgow), Sansom (Glasgow) and Carlin (Glasgow) groups at the Scotland Institute. This new MRC-funded project extends an established and productive partnership between these teams to interrogate the role and regulation of neutrophils in liver disease. Building on previous work (https: // doi.org/10.15252/embj.2020106048) which implicates neutrophils in the development of liver senescence, we will now generate mechanistic understanding of the relationship between liver ageing and inflammation.
You will use sophisticated genetic models of senescence and provide detailed characterisation of the immune and non-immune cellular response using a multi- parameter flow cytometry / transcriptomic / imaging approach. You will be supported by a group of scientists with expertise in these cutting-edge approaches and state-of-the-art research facilities and technical support. A dedicated bioinformatics post will work alongside you to maximise output.
You should hold a PhD in immunology, cell biology or a related discipline with an interest in ageing and cellular senescence. Experience in high parameter flow cytometry and mouse in vivo work would be highly desirable but we are happy to develop the right candidate. Enthusiasm and drive for the work are essential. This is a multi-lab project so the ideal candidate would be accountable for delivering the goals of the project with an appropriate level of independence and teamworking. Great communication skills will be key to doing this successfully.
For informal enquires please contact Leo Carlin ( [email protected] ) or Derek Mann ( [email protected] )
Postdoc support
Postdocs are key members of our research community, and we offer them a range of opportunities to train and develop as researchers while they are with us:
Equality, Diversity and Inclusion
Our overarching research ethos at the Institute is about excellence, honesty, openness, accountability and integrity. The diversity of our staff and students is also what makes the Institute such a vibrant place to work and advance discoveries in cancer research. Family friendly policies, our collaborative ethos, a focus on good mental health and well-being and opportunities for all help to create an enjoyable and inclusive workplace where your voice matters.
The Institute is also committed to increasing the number of female scientists at the postdoc level and beyond and encourages female applicants to apply. We have recently introduced a highly attractive maternity policy which provides 12-18 months support and funding for postdocs wishing to take time off to spend with their children amongst other family friendly policies.
Employee Benefits
Closing Date for Applications: 08 December 2023
Job details
Title
Postdoctoral Research Scientist - Dr Leo Carlin
Employer
Cancer Research UK
Location
United Kingdom
Published
November 16, 2023
Application deadline
December 08, 2023
Job type
Postdoc
Field
Biology,Chemistry,Medicine,Physics
About the employer
Cancer Research UK is a cancer research and awareness charity in the United Kingdom and Isle of Man, formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. As the world's largest independent cancer research charity it conducts research by the charity's own staff and by its grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.
Cancer Research UK is the world’s leading charity dedicated to beating cancer through research. They have discovered new ways to prevent, diagnose and treat cancer that together have saved millions of lives across the world. Cancer Research UK has been at the heart of the progress that has already seen survival rates double in the last thirty years. But one in three of us will still get cancer at some point. Our groundbreaking work, funded entirely by the public (It raises money through donations, legacies, community fundraising, events, retail and corporate partnerships. Over 40,000 people are regular volunteers), will help ensure that millions more people will survive. Cancer Research UK works in partnership with others to achieve the greatest impact in the global fight against cancer. They provide life-changing information to anyone affected by cancer, run awareness initiatives so that cancer can be detected early, and help people reduce their risk of the disease. Their campaigning and lobbying keeps cancer at the top of the political agenda. Cancer Research UK became full UICC member in 1986.